通过巨细胞表型调节,对抗肝癌的Polygonatum sibiricum多糖的免疫调节功能和抗癌作用
Maodong Leng1, Huiqin Jiang2, Haiyan Lan3
1Department of Clinical Laboratory, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, PR China; Department of Clinical Laboratory, Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou 450000, PR China.
International journal of biological macromolecules
|June 22, 2025
概括
聚糖 (PSP) 调节瘤相关巨细胞 (TAMs) 从M2到M1表型,抑制肝癌. 这通过TLR4介导的MyD88依赖途径发生,提供了一种新的癌症治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 传统中医药中的多糖类具有免疫调节作用.
- 聚糖 (PSP) 显示出调节瘤微环境的潜力.
- 与瘤相关的巨细胞 (TAMs) 在癌症进展和免疫规避中发挥着关键作用.
研究的目的:
- 调查PSP的免疫调节和抗癌作用.
- 阐明PSP对TAMs作用的基础分子机制.
- 在肝癌模型中评估PSP的疗效.
主要方法:
- 在体外巨细胞极化试验.
- 对TLR4介导的MyD88依赖信号通路的分析.
- 在体内研究使用肝癌小鼠模型.
- 免疫组织化学和免疫光测试用于评估TAM表型.
主要成果:
- 在体外,PSP有效地将M2 TAM转移到M1表型中.
- PSP的免疫调节作用是由TLR4-MyD88通路调节的.
- 在体内,PSP在肝癌中显示出显著的瘤抑制作用.
- 在瘤组织中,PSP治疗增加了CD86+TAM,降低了CD206+TAM.
结论:
- 通过将TAM重编程为M1表型,PSP具有免疫调节和抗癌作用.
- 通过TLR4介导的MyD88依赖途径对PSP的作用机制至关重要.
- 在肝癌治疗中,PSP是一个有前途的治疗策略.
更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


